Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].
J Affect Disord – October 10, 2025
Source: PubMed
Summary
Accuracy in scientific reporting strengthens our understanding of emerging therapies. Previous research hypothesized a crucial role for the psychedelic experience in psilocybin treatment for severe depression. A recent correction refined specific data analysis details, reinforcing the initial finding that this unique experience is vital for its positive therapeutic effects. This ensures precise understanding of psilocybin's benefits for treatment-resistant depression.
Abstract
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].